Stay updated on Linzagolix for Endometriosis Pain Clinical Trial
Sign up to get notified when there's something new on the Linzagolix for Endometriosis Pain Clinical Trial page.

Latest updates to the Linzagolix for Endometriosis Pain Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded an informational note that PubMed publications are automatically populated for the study and may not all pertain to it, and updated the page revision to v3.3.2. The previous statement about PubMed-sourced publications being automatically created by ClinicalTrials.gov Identifier (NCT Number) was removed.SummaryDifference0.1%

- Check16 days agoChange DetectedAdministrative notice about government funding and NIH operating status was removed. There are no changes to trial details or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check38 days agoChange DetectedResults for primary outcomes were posted (Month 3 dysmenorrhea and non-menstrual pelvic pain). The page now references the posting date and related publications.SummaryDifference0.3%

- Check59 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference3%

- Check67 days agoChange DetectedAdded a new revision tag v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) as well as the earlier revision tag v3.0.2.SummaryDifference0.4%

- Check81 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No substantive content changes were detected.SummaryDifference0.2%

Stay in the know with updates to Linzagolix for Endometriosis Pain Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Linzagolix for Endometriosis Pain Clinical Trial page.